title: Pulmonary capillary pressure measurement from pulmonary artery occlusion pressure decay profile analysis in sheep.
abstract: Pulmonary capillary pressure (Ppc), the major factor responsible for pulmonary edema, cannot be directly measured in intact subjects but may be estimated by analysis of the pressure decay profile after pulmonary artery catheter balloon inflation. We compared three different methods of pulmonary artery occlusion pressure (Ppao) decay profile analysis to estimates of Ppc derived from lymph flow measurements in halothane-anesthesized sheep. The relationship between Ppc and lymph flow was first determined by increasing Ppc by left atrial balloon inflation, and was then used to determine Ppc during pulmonary hypertension produced by infusion of a thromboxane analog. All three methods of Ppao decay profile analysis demonstrated a correlation with Ppc estimated from lymph flow. However, the method using a single exponential analysis significantly overestimated Ppc, and none of the methods reliably estimated changes in the longitudinal distribution of pulmonary vascular resistance during pulmonary hypertension. These results suggest that Ppao decay profile analysis as currently performed has limited application.
authors.affiliation: Department of Anesthesia, Stanford University School of Medicine, CA 94305, USA.
authors.forename: G E
authors.initials: GE
authors.lastname: Wakerlin
authors.forename: J C
authors.initials: JC
authors.lastname: Finn
authors.forename: L C
authors.initials: LC
authors.lastname: Siegel
authors.forename: G V
authors.initials: GV
authors.lastname: Benson
authors.forename: T F
authors.initials: TF
authors.lastname: Flavin
authors.forename: R G
authors.initials: RG
authors.lastname: Pearl
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000769:Anesthesia, Inhalation; D000818:Animals; D002196:Capillaries / Q000503:physiopathology; D006328:Cardiac Catheterization; D002404:Catheterization; D006221:Halothane / Q000008:administration & dosage; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D008196:Lymph / Q000378:metabolism; D008297:Male; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011651:Pulmonary Artery / Q000502:physiology*; D011654:Pulmonary Edema / Q000503:physiopathology; D011669:Pulmonary Wedge Pressure; D015203:Reproducibility of Results; D012756:Sheep; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000494:pharmacology; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D011450:Prostaglandin Endoperoxides, Synthetic; D014662:Vasoconstrictor Agents; D013928:Thromboxane A2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D006221:Halothane